...
...
Next Story

Amid Covid-19 surge, govt tells states to set up 24x7 testing booths

The move comes at a time when several countries are struggling to keep up with the Covid-19 testing demand after the Omicron variant sent their outbreaks spiralling into record number of cases.

Updated on: Jan 1, 2022, 04:46:19 IST
Advertisement

The Union government has directed states to set up 24x7 rapid Covid testing booths at convenient locations to facilitate early testing and quick isolation in case of a surge in cases.

Deoghar, Dec 31 (ANI): A healthcare worker inoculates a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination drive amid the spike in Omicron cases, at Karo village, in Deoghar on Friday. (ANI Photo) (Somnath Sen)
Deoghar, Dec 31 (ANI): A healthcare worker inoculates a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination drive amid the spike in Omicron cases, at Karo village, in Deoghar on Friday. (ANI Photo) (Somnath Sen)

The move comes at a time when several countries are struggling to keep up with the Covid-19 testing demand after the Omicron variant sent their outbreaks spiralling into record number of cases.

Also Read | Another muted New Year's Eve as tally continues to rise

In a letter written to states and union territories on Friday, the chief of the Indian Council of Medical Research (ICMR), Balram Bhargava, and Union health secretary, Rajesh Bhushan, said: “Multiple rapid antigen test (RAT) booths must be set up in identified geographies and operationalized on a 24x7 basis to offer widespread testing and easier access to all citizens.”

The directive also says in case of a surge, all fever cases with or without other Covid-like symptoms must be tested for Covid-19.

People need to remain in home isolation and follow government guidelines till the time test results come.

Several parts of the country are now recording a large surge in numbers as well as test positivity rate. The surge is expected to pressure the testing capacity as well as contact-tracing efforts.

As of now, India has a network of 3,117 molecular testing laboratories, with a capacity of at least 2 million tests per day.

Rapid tests have been allowed at government and private health care facilities including all hospitals, dispensaries, nursing homes, clinics, district hospitals, primary health centers etc. No accreditation is required for undertaking rapid antigen testing by any health care facility, according to the centre’s directive.

To run the booths efficiently, states have been asked to engage appropriate medical and paramedical staff specifically for the testing booths, at convenient locations.

According to experts, rapid test works well during the surge scenario. “When case load is high, it will show in the rapid test as positives are true positives. For large scale testing in such a scenario this works well to identify and isolate infected persons,” said Dr Amita Jain, head of microbiology department, King George’s Medical University, Lucknow.

The new guidelines also encourage use of self-tests or home tests for symptomatic individuals; and seven such home testing kits have been approved so far, with two of them also available on government e marketplace (GeM) launched by the ministry of commerce.

The states have been asked to put emergency procurement procedures in place to avoid facing any shortage during the peak of cases.

“It is necessary to institute emergency procurement procedures to facilitate unhindered supply of diagnostic commodities for Covid-19 in your state/UT. You may appropriately refine the state procurement procedures for emergency procurement from market to expedite the process,” read the guidelines.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe